Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey S A Stringer

Showing results (121-130 of 208) with videos related to

Pageof 21
Sort By:
Biomed Research International|January 29, 2016
Temporal Trends and Predictors of Modern Contraceptive Use in Lusaka, Zambia, 2004-2011Nancy L Hancock, Carla J Chibwesha, Marie C D Stoner, et al.
Obstetrics and Gynecology|March 14, 2020
Machine Learning and Statistical Models to Predict Postpartum HemorrhageKartik K Venkatesh, Robert A Strauss, Chad A Grotegut, et al.
AIDS (London, England)|January 18, 2013
Field effectiveness of combination antiretroviral prophylaxis for the prevention of mother-to-child HIV transmission in rural ZambiaMatthew G Gartland, Namwinga T Chintu, Michelle S Li, et al.
Plos One|March 8, 2013
Monitoring of antiretroviral therapy and mortality in HIV programmes in Malawi, South Africa and Zambia: mathematical modelling studyJanne Estill, Matthias Egger, Leigh F Johnson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 30, 2007
Complete blood cell count as a surrogate CD4 cell marker for HIV monitoring in resource-limited settingsRay Y Chen, Andrew O Westfall, J Michael Hardin, et al.
Lancet (London, England)|November 13, 2007
Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trialBenjamin H Chi, Moses Sinkala, Felistas Mbewe, et al.
Plos One|September 24, 2020
Acceptability of a trial of vaginal progesterone for the prevention of preterm birth among HIV-infected women in Lusaka, Zambia: A mixed methods studyJoan T Price, Chileshe M Mabula-Bwalya, Bethany L Freeman, et al.
Journal of Lower Genital Tract Disease|July 2, 2010
eC3--a modern telecommunications matrix for cervical cancer prevention in ZambiaGroesbeck P Parham, Mulindi H Mwanahamuntu, Krista S Pfaendler, et al.
Maternal and Child Health Journal|October 24, 2025
Mid-Trimester Allostatic Load and Spontaneous Preterm Birth in a Cohort of Pregnant Women Living with HIV in ZambiaKatelyn J Rittenhouse, Bellington Vwalika, Yuri V Sebastião, et al.
Plos One|October 3, 2019
Highly diverse anaerobe-predominant vaginal microbiota among HIV-infected pregnant women in ZambiaJoan T Price, Bellington Vwalika, Marcia Hobbs, et al.
Pageof 21

Showing results (121-130 of 208) with videos related to

Sort By:
Pageof 21
Biomed Research International|January 29, 2016
Temporal Trends and Predictors of Modern Contraceptive Use in Lusaka, Zambia, 2004-2011Nancy L Hancock, Carla J Chibwesha, Marie C D Stoner, et al.
Obstetrics and Gynecology|March 14, 2020
Machine Learning and Statistical Models to Predict Postpartum HemorrhageKartik K Venkatesh, Robert A Strauss, Chad A Grotegut, et al.
AIDS (London, England)|January 18, 2013
Field effectiveness of combination antiretroviral prophylaxis for the prevention of mother-to-child HIV transmission in rural ZambiaMatthew G Gartland, Namwinga T Chintu, Michelle S Li, et al.
Plos One|March 8, 2013
Monitoring of antiretroviral therapy and mortality in HIV programmes in Malawi, South Africa and Zambia: mathematical modelling studyJanne Estill, Matthias Egger, Leigh F Johnson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 30, 2007
Complete blood cell count as a surrogate CD4 cell marker for HIV monitoring in resource-limited settingsRay Y Chen, Andrew O Westfall, J Michael Hardin, et al.
Lancet (London, England)|November 13, 2007
Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trialBenjamin H Chi, Moses Sinkala, Felistas Mbewe, et al.
Plos One|September 24, 2020
Acceptability of a trial of vaginal progesterone for the prevention of preterm birth among HIV-infected women in Lusaka, Zambia: A mixed methods studyJoan T Price, Chileshe M Mabula-Bwalya, Bethany L Freeman, et al.
Journal of Lower Genital Tract Disease|July 2, 2010
eC3--a modern telecommunications matrix for cervical cancer prevention in ZambiaGroesbeck P Parham, Mulindi H Mwanahamuntu, Krista S Pfaendler, et al.
Maternal and Child Health Journal|October 24, 2025
Mid-Trimester Allostatic Load and Spontaneous Preterm Birth in a Cohort of Pregnant Women Living with HIV in ZambiaKatelyn J Rittenhouse, Bellington Vwalika, Yuri V Sebastião, et al.
Plos One|October 3, 2019
Highly diverse anaerobe-predominant vaginal microbiota among HIV-infected pregnant women in ZambiaJoan T Price, Bellington Vwalika, Marcia Hobbs, et al.
Pageof 21